KristofferSkaalum

M.D., PhD at Department of Infectious Diseases, Aarhus University Hospital.

[The Lancet Reg Health-Europe @LancetRH_Europe]

A new randomized, phase 2, crossover trial shows that #CoQ10 treatment does not appear to significantly reduce the number or severity of Post COVID-19 condition (#PCC) related symptoms when compared to placebo.

@KSkaalum @SteffenLeth @prof_ost

https://t.co/NnQnJuXIUA

[KristofferSkaalum @KSkaalum]

Long COVID: An opportunity to focus on post-acute infection syndromes https://t.co/ZSERn0VfOi